SCLC lung anatomy diagram showing small cell lung cancer tumor location in bronchial region

SCLC 2026: 40% Longer Survival + $31K/Mo Costs – New Treatment Breakthrough Guide

SCLC patients now have 40% longer survival with tarlatamab therapy approved in 2024. Learn about $31K monthly treatment costs, insurance coverage, and financial assistance programs for 2026.

Small cell lung cancer anatomy illustration showing lung tumor cells under magnification

Small Cell Lung Cancer Survival Rates in 2026: What Stage-by-Stage Data Really Means & How New Immunotherapy Is Changing Outcomes

Small cell lung cancer survival rates range from 3% to 27% by stage — but 2026 immunotherapy breakthroughs are extending lives beyond what those numbers suggest. This guide explains every stage, what the survival data actually means for individual patients, and the newest treatment combinations giving oncologists real hope.